Valued at $83.0M at its later-stage round, Jul 2025. Nothing has traded since.
- ·Watch Tulavi Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Tulavi Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2021 | Seed Round | $1.0M | ▮ | ▮ |
| Feb 2021 | Early Stage VC | $7.5M | ▮ | ▮ |
| May 2020 | Seed Round | $3.0M | ▮ | ▮ |
| Apr 2018 | Seed Round | $3.0M | ▮ | ▮ |
Membership and data by Private Market View
Tulavi Therapeutics valuation
Tulavi Therapeutics was valued at $83 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Tulavi Therapeutics raised?
Tulavi Therapeutics has raised $34 million in total; 4 of its rounds are on record, from 2018 on. The largest on record was a $7.5 million early-stage round in Feb 2021; the most recent was a $1 million seed round in Dec 2021.
Tulavi Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently in Dec 2021 ($1 million sold to 9 investors).
How Tulavi Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Tulavi Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Tulavi Therapeutics
- What is Tulavi Therapeutics worth?
- Tulavi Therapeutics is valued at $83.0M as of Oct 2026. Valued at $83.0M at its later-stage round, Jul 2025. Nothing has traded since.
- How much has Tulavi Therapeutics raised?
- Tulavi Therapeutics has raised $34.0M in total funding across 4 recorded rounds.
- When did Tulavi Therapeutics last raise?
- Tulavi Therapeutics last raised in Dec 2021 (Seed Round), raising $1.0M.